Cambodia is among 11 nations set to
benefit from a US$225 million anti-malarial fund launched in Oslo on
Friday by Roll-Back Malaria, a public private partnership that includes
UNICEF, the World Bank, private donors and various national
governments. The fund will cut the cost of drugs for resistant malarial
strains from $6-$10 to between $0.20 and $0.50 through international
subsidies and negotiations with pharmaceutical companies. Cambodia and
the 10 African nations selected are among the worst nations affected by
malaria, a disease that is estimated to kill 2,000 children a day
worldwide.
Contact PhnomPenh Post for full article
Post Media Co LtdThe Elements Condominium, Level 7
Hun Sen Boulevard
Phum Tuol Roka III
Sangkat Chak Angre Krom, Khan Meanchey
12353 Phnom Penh
Cambodia
Telegram: 092 555 741
Email: [email protected]